Submission Details
| 510(k) Number | K170614 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 01, 2017 |
| Decision Date | October 19, 2017 |
| Days to Decision | 232 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K170614 is an FDA 510(k) clearance for the CareSens N Premier Blood Glucose Monitoring System, CareSens N Premier BT Blood Glucose Monitoring System, a System, Test, Blood Glucose, Over The Counter (Class II — Special Controls, product code NBW), submitted by I-Sens, Inc. (Seoul, KR). The FDA issued a Cleared decision on October 19, 2017, 232 days after receiving the submission on March 1, 2017. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K170614 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 01, 2017 |
| Decision Date | October 19, 2017 |
| Days to Decision | 232 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBW — System, Test, Blood Glucose, Over The Counter |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |